4 main factors for choosing the UAE within the final testing stations

The Corona vaccine race passes by Abu Dhabi ... and a global watch for the results

picture

The UAE has succeeded in strengthening its regional position as one of the most important international players, within the framework of strengthening international solidarity and cooperation in efforts to deal with the exceptional circumstances imposed by the outbreak of the Coronavirus.

Abu Dhabi has become a major stop in the global effort to reach an effective vaccine that ends the biggest challenge humanity has witnessed in the 21st century.

The UAE has entered into a partnership with the most prominent vaccine developers in the People's Republic of China and the Russian Federation. Clinical trials are currently underway in their final stages on the two most prominent vaccines that have been announced, which are the Chinese company "Sinopharma CNPG" and the Russian "Sputnik v" , Amid global anticipation for the final results.

Four main factors contributed to choosing the UAE as one of the most prominent final testing stations for the "Covid" vaccine, based on the confidence in its position, the clear vision of the country's leadership, and its belief that reaching a final solution to the crisis must come through broad international solidarity and cooperation, in addition to the quality and efficiency of its health system, And societal willingness to volunteer to conduct experiments with a diverse population that includes more than 200 nationalities.

The CEO of the Russian Direct Investment Fund, Kirill Dmitriev, confirmed that the start of clinical trials of the Russian vaccine in the UAE reflects the confidence in the capabilities and experiences that the UAE puts in place to serve efforts to reach a decisive treatment for the pandemic, and said that the UAE has proven to be one of the most advanced countries in combating 'Covid- 19 », and we are pleased to start clinical trials outside Russia from Abu Dhabi, stressing that the announcement of the start of the registration of volunteers will be in coordination with the concerned authorities in the UAE soon.

The UAE represents an ideal environment for conducting clinical trials in the region, as the country has an advanced health system served by a wide range of government hospitals and medical centers, a long list of hospitals and private treatment centers, and the private sector has contributed significantly to strengthening the country's position in the efforts to address the pandemic. G42 Healthcare », one of the subsidiaries of the G42 Group, which is based in Abu Dhabi, is one of the most prominent companies active in providing medical solutions to deal with the pandemic, and it has become one of the most important global companies in this field, and the great turnout of volunteers contributed to the phase The third of the clinical trials of the Chinese vaccine in enhancing the UAE's experience in this field, as the first trials of the third phase achieved an important achievement as one of the largest in the world, by attracting more than 31,000 volunteers belonging to more than 120 nationalities within six weeks only.

The diversity of the population, which includes the presence of more than 200 nationalities, provides an appropriate opportunity for more accurate and reliable results, according to medical sources.

The UAE's hosting of clinical trials of the emerging coronavirus vaccines comes in line with the vision of its leadership, which has emphasized, since the beginning of the crisis, the importance of mobilizing international efforts and energies to overcome the crisis, and its commitment to cooperation and solidarity with various countries of the world, and to secure everything necessary to secure the health and safety of its residents.

The UAE translated the vision of its leadership through a wide range of humanitarian initiatives and stances, which included support for efforts to confront the epidemic in many countries around the world, which suffered a shortage of medical equipment, and then participated in many campaigns to evacuate nationals of countries stuck in the epicenters of the outbreak, and many local decisions. Guarantee of market stability and investor protection.

In mid-July, the UAE began the first global clinical trials for the third phase of a possible vaccine, which is listed under the umbrella of the World Health Organization, produced by the Chinese company, "Sinopharma CNPG".

The UAE authorized the emergency use of the "Covid-19" vaccine, to make it available to the groups most dealing with "Covid-19" sufferers of the first line of defense champions, after the results of the preclinical phase studies, and the first and second stages which showed that the vaccine is safe and effective, while the phase is going. The third is efficient and includes a large number of volunteers.

Kirill Dmitriev:

"The start of clinical trials for the Russian vaccine in the UAE reflects confidence in its capabilities and experiences."

31

A thousand volunteers, belonging to more than 120 nationalities, were attracted by the first trials of the third phase within six weeks.

Follow our latest local and sports news, and the latest political and economic developments via Google news